Alpha-2 Macroglobulin
Alpha-2 Macroglobulin (A2M) is a secreted protease inhibitor and cytokine transporter that traps proteinases of all four classes using a bait-and-trap mechanism. It is also known by the aliases FWP007, S863-7 and CPAMD5. Browse Assay Genie's current range of Alpha-2 Macroglobulin research reagents below, or read on for the biology behind the target.
Alpha-2 macroglobulin is able to inhibit all four classes of proteinases through a distinctive trapping mechanism. The protein carries a peptide stretch known as the bait region, which contains specific cleavage sites for different proteinases. When a proteinase cleaves the bait region, a conformational change is induced that traps the enzyme. The entrapped proteinase remains active against low molecular weight substrates, whereas its activity against high molecular weight substrates is greatly reduced. Following cleavage in the bait region, a thioester bond is hydrolysed and mediates covalent binding of the protein to the proteinase.
The A2M gene encodes a protease inhibitor and cytokine transporter. Its bait-and-trap mechanism acts against a broad spectrum of proteases, including trypsin, thrombin and collagenase. It can also inhibit inflammatory cytokines, and so disrupts inflammatory cascades. The A2M protein is secreted and belongs to the protease inhibitor I39 (alpha-2-macroglobulin) family, which is also the HGNC gene group for the locus. The mouse and rat orthologs are both named A2m.
Mutations in A2M are a cause of alpha-2-macroglobulin deficiency. The gene is also implicated in Alzheimer's disease because the protein mediates the clearance and degradation of A-beta, the major component of beta-amyloid deposits. A related pseudogene has been identified on the p arm of chromosome 12. Researchers studying proteolysis, inflammation or amyloid biology often use an A2M antibody or A2M ELISA kit to investigate this protein.
A2M traps proteinases of all four classes through its bait region, making it a reference model for broad-spectrum, non-selective protease inhibition.
As a cytokine transporter that can inhibit inflammatory cytokines, A2M is studied for its role in disrupting inflammatory cascades.
A2M is implicated in Alzheimer's disease through its ability to mediate clearance and degradation of A-beta, the main component of beta-amyloid deposits.
Mutations in the A2M gene cause alpha-2-macroglobulin deficiency, providing a basis for investigating how loss of this inhibitor affects protease regulation.
Alpha-2 macroglobulin inhibits all four classes of proteinases by trapping. Cleavage of its bait region causes a conformational change that entraps the enzyme, and a thioester bond then mediates covalent binding. It also transports cytokines and can inhibit inflammatory cytokines.
A2M is the HGNC symbol for alpha-2-macroglobulin. Recorded aliases are FWP007, S863-7 and CPAMD5. The UniProt protein name is Alpha-2-macroglobulin, and the protein belongs to the protease inhibitor I39 family.
Mutations in A2M cause alpha-2-macroglobulin deficiency, and the gene is implicated in Alzheimer's disease through A-beta clearance. Mouse and rat both have an ortholog named A2m; check the datasheet of any product for its validated reactivity.
Other protease inhibitors, proteases, cytokines and amyloid-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01023; product specifications from Assay Genie datasheets.